Effectiveness of the WearME System for COPD Severity and Respiratory Function

Part of paid clinical trials in Baltimore, Maryland.

Sponsor
LASARRUS Clinic and Research Center
Study ID
NCT06751537
Status
Recruiting

Conditions

  • Chronic Obstructive Pulmonary Disease (COPD)

Eligibility Criteria

Sex
ALL
Age
21 Years - 100 Years
Healthy Volunteers
Not accepted

Study Details

This observational study evaluates the effectiveness of the WearME system in monitoring COPD severity and respiratory function by comparing its measurements to standard spirometry, capnography, and other clinical assessments in 128 COPD participants.

Key Dates

Start date
May 29, 2025
Status verified
Sep 2025
Primary completion
Jan 31, 2026
Completion
Feb 28, 2026

Study Design

Enrollment
128 participants (estimated)

Arms

  • Arm: COPD Participants
    Participants are wearing the WearME device and undergoing reference testing

Primary Outcome Measure

Agreement between WearME-Pro system and gold standard devices for FEV1 measurements, stratified by COPD severity. [ Time Frame: Within 6 months of study start. ]

Central Contacts

Locations (2)

FacilityCityStateZIPSite coordinators
Johns HopkinsBaltimoreMaryland21224
Chathurangi Pathiravasan, PhD
617-416-6222
Adrian S Dobs, MD
443-604-3745
Edward Chen, MD (SUB_INVESTIGATOR)
TidalHealthSalisburyMaryland21801
Robert L Joyner, PhD
410-543-7017
Sandra Fetko, MSN
410-912-6045
Robert T Chasse, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Baltimore, MD

Related Studies